Pompano Beach, Fla., May 13, 2014 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals announced that the Company will present at the Third Annual Marcum MicroCap Conference in New York City on May 29, 2014 at the Grand Hyatt New York. Since 2012, the Marcum conference has introduced investors to promising undiscovered companies with a market capitalization of under $500 million. As part of the conference, DS Healthcare will participate in one-on-one meetings with investors and other companies.
"This is an excellent opportunity from which to get exposure and increase investor awareness," said DS Healthcare CEO Daniel Khesin. "We believe that with our cutting-edge topical technologies, products, vast distribution and consistent growing revenues, we are a very compelling investment opportunity that has not yet been discovered."
Presentation time and details:
• Location: Grand Hyatt New York (109 E 42nd Street, New York, NY 10017)
• Date: May 29, 2014
• Time: 10:00 - 10:30 AM EST
• Room: Broadway
To schedule a one-on-one meeting with management, please contact Abner Silva by email at: Abner@DSHealthgroup.com
About the Marcum MicroCap Conference
The Marcum MicroCap Conference is dedicated to introducing investors to the very best, undiscovered companies under $500 million in market capitalization. Launched in 2012, the annual Marcum MicroCap Conference features presentations by CEOs and CFOs from promising high-growth companies, the top picks by some of the most astute analysts following small caps, and thoughtful commentary on successful investment strategies and sectors. This invitation-only event attracts top fund managers and qualified high net worth investors who focus on small cap equities. One-on-one meetings are available for company management teams and qualified investors.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com
Forward-looking statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.